Division of Gastroenterology and Hepatology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.
Department of Medicine, Corporal Michael J. Crescenz VA Medical Center, Philadelphia, PA, USA.
Dig Dis Sci. 2023 Apr;68(4):1632-1640. doi: 10.1007/s10620-022-07680-9. Epub 2022 Sep 9.
Acute-on-chronic liver failure (ACLF) is a syndrome in patients with cirrhosis with high short-term mortality. Infection is a frequent precipitant of ACLF; however, it is unclear if prognosis varies by difference infectious sources. To address this knowledge gap, we utilized a large national database of patients with cirrhosis.
This was a retrospective cohort study of patients with cirrhosis in the Veterans Health Administration between 2008 and 2016. First ACLF hospitalizations were identified and infections were classified using validated algorithms, categorized as bacteremia, fungal, spontaneous bacterial peritonitis (SBP), pyelonephritis/urinary tract infection, or skin and soft tissue/musculoskeletal infection (SST/MSK). Inverse probability treatment weighing for infection-associated ACLF followed by multivariable logistic regression was used to evaluate the association between infection type and 90-day mortality.
A total 22,589 ACLF hospitalizations were included, 3998 (17.7%) of which had ACLF grade 3. Infection was associated with 12,405 (54.9%) of ACLF hospitalizations. In regression models, SBP was associated with a 1.79-fold increased odds of 90-day mortality vs. no infection (95% confidence interval [CI] 1.58-2.02, p < 0.001), whereas SST/MSK infections had a lower relative odds of mortality (odds ratio 0.48, 95% CI 0.42-0.53, p < 0.001). There was a significant interaction between infection category and ACLF grade on the outcome of 90-day mortality (p < 0.001).
The impact of infection on short-term mortality in ACLF varies depending on the source of infection. This has relevance for ACLF prognostication and challenges previous notions that bacterial infection invariably worsens prognosis among all patients with ACLF.
急性肝衰竭(ACLF)是一种在肝硬化患者中发生的综合征,其短期死亡率较高。感染是 ACLF 的常见诱因;然而,尚不清楚不同感染源的预后是否存在差异。为了弥补这一知识空白,我们利用了一个大型的全国性肝硬化患者数据库。
这是一项回顾性队列研究,纳入了 2008 年至 2016 年期间退伍军人健康管理局(Veterans Health Administration)中患有肝硬化的患者。首先确定首次 ACLF 住院患者,并使用经过验证的算法对感染进行分类,分为菌血症、真菌感染、自发性细菌性腹膜炎(SBP)、肾盂肾炎/尿路感染、皮肤和软组织/肌肉骨骼感染(SST/MSK)。采用感染相关性 ACLF 的逆概率治疗加权法和多变量逻辑回归来评估感染类型与 90 天死亡率之间的关联。
共纳入 22589 例 ACLF 住院患者,其中 3998 例(17.7%)患有 ACLF 3 级。感染与 12405 例(54.9%)ACLF 住院患者有关。在回归模型中,与无感染相比,SBP 与 90 天死亡率增加 1.79 倍的几率相关(95%置信区间[CI]1.58-2.02,p<0.001),而 SST/MSK 感染的死亡相对几率较低(比值比 0.48,95%CI0.42-0.53,p<0.001)。感染类别和 ACLF 分级对 90 天死亡率的结果存在显著交互作用(p<0.001)。
感染对 ACLF 短期死亡率的影响因感染源而异。这与 ACLF 的预后相关,并挑战了以前的观点,即细菌感染总是会使所有 ACLF 患者的预后恶化。